RLMD - Relmada Therapeutics Inc. (RLMD) CEO Sergio Traversa on Q1 2021 Results - Earnings Call Transcript
Relmada Therapeutics, Inc. (RLMD) Q1 2021 Results Earnings Conference Call May 12, 2021, 04:30 PM ET Company Participants Tim McCarthy - LifeSci Advisors Sergio Traversa - Chief Executive Officer Chuck Ence - Chief Accounting and Compliance Officer Conference Call Participants Andrew Tsai - Jefferies Joon Lee - Truist Yatin Suneja - Guggenheim Partners Jay Olson - Oppenheimer Presentation Operator Good afternoon, ladies and gentlemen. And thank you for standing by. Welcome to the Relmada Therapeutics Incorporated First Quarter 2021 Financial Results Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to your host Tim McCarthy with LifeSci Advisors. Tim McCarthy Thank you, operator. And thank you all for joining us this afternoon. With me on today’s call our Chief Executive Officer, Dr. Sergio
For further details see:
Relmada Therapeutics, Inc. (RLMD) CEO Sergio Traversa on Q1 2021 Results - Earnings Call Transcript